# The Medicines (Products for Human Use) (Fees) Regulations 2012, Regulation 5: Fee for scientific advice: classification of a medicinal product


(1) The fee payable by a person with whom the licensing authority holds a meeting to provide scientific advice in connection with the classification of a relevant medicinal product, is—
(a) £2,986, if the advice relates to a product which, if reclassified, will be available on general sale; and
(b) £3,917, if the advice relates to a product which, if reclassified, will be available without a prescription from a pharmacy.
(2) For the purposes of this regulation, a product is on general sale if it is a medicinal product of a description or falling within a class specified in an Order made under section 51 (general sale lists) of the Act.

---
Source: https://www.legislation.gov.uk/nisr/2012/134/regulation/5 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2012/regulation-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.